CAMBRIDGE, Mass.--(BUSINESS WIRE)--Feb. 21, 2019--
Ra Pharmaceuticals, Inc. (Nasdaq:RARX) today announced that Ramin
Farzaneh-Far, M.D., Chief Medical Officer of Ra Pharma, will present at
the 8th Annual SVB Leerink Global Healthcare Conference on Thursday,
February 28, 2019 at 2:30 p.m. E.T. The conference is being held at the
Lotte New York Palace, New York, NY.
The presentation will be webcast live and can be accessed by visiting
the investor relations section of the Company’s website, www.rapharma.com.
A replay of the presentation will also be available and archived on the
site for three weeks.
About Ra Pharmaceuticals
Ra Pharmaceuticals is a clinical stage biopharmaceutical company
focusing on the development of next-generation therapeutics for
complement-mediated diseases. The Company discovers and develops
peptides and small molecules to target key components of the complement
cascade. For more information, please visit: www.rapharma.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20190221005129/en/
Source: Ra Pharmaceuticals, Inc.
Natalie Wildenradt, 617-209-5324
David Rosen, 212-600-1902